![]() |
市場調查報告書
商品編碼
2106339
2034年積極老化營養市場預測-按產品類型、成分、健康益處、劑型、通路、最終用戶和地區分類的全球分析Active Aging Nutrition Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient, Health Benefit, Form, Distribution Channel, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球積極老化營養市場將達到 200 億美元,並在預測期內以 10.9% 的複合年成長率成長,到 2034 年達到 373 億美元。
老年營養市場涵蓋專門配製的膳食補充劑、功能性食品和醫用營養產品,旨在支持40歲及以上成年人的生理健康、認知功能、身體活動和整體生活品質 (QOL)。這些產品含有適量的蛋白質、ω-3脂肪酸、機能性食品、礦物質、益生菌和生物活性化合物,以解決與老齡化相關的營養缺乏、肌肉萎縮、骨骼密度下降和代謝變化等問題。其技術包括先進的配方科學、增強的營養物質生物利用度以及已證實對老年人有效作用的臨床調查方法。老年營養有助於實現醫療保健目標,使老年人在整個生命歷程中保持獨立、活力和身體機能。
高齡化社會
全球人口結構正以前所未有的速度向老化轉變,隨著醫療保健系統和個人將預防性健康管理置於被動治療之上,對積極老化營養產品的需求持續成長。世界衛生組織(世衛組織)預測,到2030年,全球六分之一的人口將超過60歲。這一不斷成長的人口認知到營養狀況與功能獨立性之間的直接聯繫。成年子女擴大為年邁的父母購買營養補充劑。由此帶來的商業性影響是,由人口結構必然性而非週期性消費趨勢驅動的市場將出現顯著、結構性和長期的擴張,並吸引了製藥和食品公司的大量投資。
保險報銷方面的差異
有限的保險和公共醫療保障對預防性營養補充劑造成了經濟障礙,主要目標群體——收入穩定的老年消費者——難以負擔。大多數醫療保健計劃將積極老化營養產品歸類為可選的健康促進品,而非醫療必需品,因此將其排除在處方箋福利和靈活支出帳戶(FSA)之外。全面的營養補充計劃每月可能花費數百美元。這些報銷缺口對最有可能從營養支持中獲益的低收入老年人造成了不成比例的影響,阻礙了產品在價格敏感型消費群體中的市場滲透。
老年人個人化營養管理
營養基因組學、人工智慧和數位健康監測的融合,為個人化、積極老化的營養管理創造了變革性的機遇,這種管理方式可根據個人的基因譜、生物標記狀態和生活方式因素量身定做。家用檢測套組可分析營養素缺乏、發炎標記物以及影響營養代謝的基因多態性。人工智慧演算法會產生個人化的營養補充建議,並根據不斷變化的健康狀況進行調整。訂閱模式確保了攝取量的持續性和便利性。最終用戶將受益於針對其特定老齡化過程量身定做的精準營養,而非普通的複合綜合維他命。這一商機也正拓展至與醫療保健機構和保險公司健康計畫的合作。
通用產品的競爭
鈣、維生素D和omega-3脂肪酸等維持活力老化所需的必需營養素的商品化,加劇了大眾市場保健品領域的競爭,削弱了品牌溢價。大型零售商提供的自有品牌產品配方相似,價格卻低得多。大宗購買和線上價格透明化使得消費者能夠主動比較價格。這些趨勢正在擠壓品牌製造商的利潤空間,並降低其在現有成分類別中進行創新的獎勵。經臨床驗證的高級產品與商品化的非專利產品之間的市場細分,也使定位策略變得更加複雜。
新冠疫情提高了老年人對免疫健康和營養韌性的認知,加速了積極老化營養產品的普及。供應鏈中斷一度影響了維生素D和鋅補充劑等關鍵產品的原料供應。由於疫情期間老年人和看護者避免前往實體店,電子商務成為主要的銷售管道。疫情後,由於人們持續關注預防醫學和免疫支持,對這類產品的需求依然強勁。醫療保健專業人員擴大將營養干預納入新冠肺炎長期康復和整體健康維護的指導建議中。
在預測期內,營養補充劑細分市場預計將佔據最大的市場佔有率。
由於消費者對其認知度較高、零售分銷網路廣泛,且膠囊和片劑等劑型便於老年人精準服用,膳食補充劑預計將在預測期內佔據最大的市場佔有率。在醫療保健專業人士的推薦和保險公司健康計劃的推動下,膳食補充劑在藥局和保健食品商店的貨架上佔據主導地位。此細分市場包括綜合維他命、特定礦物質以及針對骨骼健康、心血管功能和認知功能維護等疾病的配方。終端用戶優先考慮產品的便利性和便攜性。這一商業性優勢反映了該細分市場的成熟度、監管的清晰度和大量的臨床證據。
預計益生菌產業在預測期內將呈現最高的複合年成長率。
在預測期內,益生菌產業預計將呈現最高的成長率,這主要得益於人們對腸道菌叢在免疫功能、營養吸收、認知功能以及發炎調節等方面發揮的核心作用的科學認知不斷加深。專為老齡化篩選的益生菌菌株能夠有效應對隨著老齡化而出現的有益腸道菌叢減少問題。研究表明,服用益生菌的老年人消化器官系統健康狀況得到改善,感染率降低,生活品質提高。腸腦軸研究及其在認知功能方面的應用正在催生跨品類的需求。微膠囊化和常溫保存配方等給藥方式的創新正在提高益生菌的存活率,並確保消費者持續攝取。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其嬰兒潮一代逐漸老齡化、醫療保健支出高企、成熟的營養補充劑文化以及完善的零售和直銷分銷體系。美國在北美地區處於領先地位,擁有全球最大的65歲及以上成年人口,醫療保健專業人士對營養干預的大力支持,以及強大的臨床研究機構檢驗了抗衰老配方的有效性。加拿大也展現出類似的消費者偏好,政府對老年人健康計畫的支持也與之類似。在墨西哥,中產階級的壯大和預期壽命的延長正在催生新的需求。該地區先進的電子商務環境為訂閱式營養支援服務提供了支援。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於中國、日本、韓國和印度等國人口老齡化速度加快、可支配收入增加、健康意識提升以及政府推行健康老齡化舉措。在中國,龐大的老齡人口和政府的「健康中國2030」策略正在推動銷售量需求成長。作為一個老化程度較高的國家,日本在老年人機能性食品和飲料的創新方面處於領先地位。在韓國,美容和健康文化也延伸到了抗衰老營養領域。在印度,越來越多富裕的老年人開始服用高階營養補充品。傳統醫學與現代營養科學的融合,正在為該地區帶來獨特的產品。
According to Stratistics MRC, the Global Active Aging Nutrition Market is accounted for $20.0 billion in 2026 and is expected to reach $37.3 billion by 2034 growing at a CAGR of 10.9% during the forecast period. Active aging nutrition encompasses specialized dietary supplements, functional foods, and medical nutrition products formulated to support physiological health, cognitive function, physical mobility, and overall quality of life in adults aged forty and above. These products deliver targeted concentrations of proteins, omega-3 fatty acids, vitamins, minerals, probiotics, and bioactive compounds that address age-related nutritional deficiencies, muscle atrophy, bone density loss, and metabolic changes. The technology encompasses advanced formulation science, nutrient bioavailability enhancement, and clinical validation methodologies that demonstrate efficacy in aging populations. Active aging nutrition serves preventive healthcare objectives, enabling older adults to maintain independence, vitality, and functional capacity throughout extended lifespans.
Aging demographics
The unprecedented global demographic shift toward older populations is creating sustained demand for active aging nutrition products as healthcare systems and individuals prioritize preventive wellness over reactive treatment. The World Health Organization projects that by 2030, one in six people worldwide will be aged sixty years or older. This expanding demographic recognizes the direct connection between nutritional status and functional independence. Adult children increasingly purchase supplements for aging parents. The commercial implication is a structural, long-term market expansion driven by demographic inevitability rather than cyclical consumer trends, attracting substantial investment from pharmaceutical and food companies.
Reimbursement gaps
The limited insurance and government reimbursement coverage for preventive nutritional supplements create affordability barriers for fixed-income elderly consumers who represent the primary target demographic. Most healthcare systems classify active aging nutrition products as discretionary wellness items rather than medically necessary interventions, excluding them from prescription coverage and flexible spending account eligibility. Out-of-pocket costs for comprehensive supplement regimens can exceed several hundred dollars monthly. These reimbursement gaps disproportionately affect lower-income seniors who may benefit most from nutritional support, constraining market penetration among price-sensitive segments.
Personalized geriatric nutrition
The convergence of nutrigenomics, artificial intelligence, and digital health monitoring is creating transformative opportunities for personalized active aging nutrition tailored to individual genetic profiles, biomarker status, and lifestyle factors. At-home testing kits analyze nutrient deficiencies, inflammation markers, and genetic polymorphisms affecting nutrient metabolism. AI algorithms generate customized supplement recommendations that evolve with changing health status. Subscription delivery models ensure compliance and convenience. End users benefit from precision nutrition that addresses their specific aging trajectories rather than generic multivitamin formulations. The commercial opportunity extends to healthcare provider partnerships and insurance wellness programs.
Generic competition
The commoditization of basic active aging nutrition ingredients, including calcium, vitamin D, and omega-3 fatty acids is intensifying price competition and eroding brand premiums in the mass-market supplement segment. Private label brands offered by major retailers provide equivalent formulations at significantly lower price points. Bulk purchasing and online price transparency enable consumers to comparison shop aggressively. These dynamics compress margins for branded manufacturers and reduce incentives for innovation in established ingredient categories. Market fragmentation between premium clinically validated products and commodity generics complicates positioning strategies.
The COVID-19 pandemic heightened awareness of immune health and nutritional resilience among aging populations, accelerating active aging nutrition adoption. Supply chain disruptions temporarily affected ingredient availability for key products, including vitamin D and zinc supplements. Mid-pandemic, e-commerce became the dominant distribution channel as seniors and caregivers avoided retail exposure. Post-pandemic, sustained emphasis on preventive health and immune support maintains elevated demand levels. Healthcare provider recommendations increasingly incorporate nutritional interventions for long-term COVID recovery and general wellness.
The dietary supplements segment is expected to be the largest during the forecast period
The dietary supplements segment is expected to account for the largest market share during the forecast period, due to the established consumer familiarity, broad retail distribution, and precise dosing capabilities that capsule and tablet formats provide for aging populations. Dietary supplements dominate pharmacy and health food store shelves, benefiting from healthcare practitioner recommendations and insurance wellness program inclusion. The segment encompasses multivitamins, targeted minerals, and condition-specific formulations addressing bone health, cardiovascular function, and cognitive preservation. End users prioritize convenience and portability. The commercial dominance reflects the segment's maturity, regulatory clarity, and extensive clinical evidence base.
The probiotics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the probiotics segment is predicted to witness the highest growth rate, driven by expanding scientific understanding of the gut microbiome's central role in immune function, nutrient absorption, cognitive health, and inflammation modulation during aging. Probiotic strains specifically selected for geriatric populations address age-related declines in beneficial gut bacteria. Clinical research demonstrates improved digestive health, reduced infection rates, and enhanced quality of life in supplemented seniors. The convergence of gut-brain axis research with cognitive health applications creates cross-category demand. Delivery innovations, including microencapsulation and shelf-stable formulations, improve viability and consumer compliance.
During the forecast period, the North America region is expected to hold the largest market share, due to the aging baby boomer population, high healthcare expenditure, established supplement culture, and extensive retail and direct-to-consumer distribution infrastructure. The United States leads with the largest population of adults over sixty-five, strong healthcare practitioner endorsement of nutritional interventions, and robust clinical research institutions validating active aging formulations. Canada demonstrates similar consumer preferences with government support for senior wellness programs. Mexico's growing middle class and increasing life expectancy create emerging demand. The region's advanced e-commerce ecosystem supports subscription-based nutrition services.
Over the forecast period, the Asia Pacific region is expected to exhibit the highest CAGR, driven by rapid population aging, rising disposable incomes, increasing health awareness, and government initiatives promoting healthy aging in countries such as China, Japan, South Korea, and India. China's massive aging population and government Healthy China 2030 strategy drive volume demand. Japan's advanced aging society pioneers functional food and beverage innovations for seniors. South Korea's beauty and wellness culture extends to anti-aging nutrition. India's growing affluent senior class adopts premium supplement regimens. The integration of traditional medicine with modern nutrition science creates unique regional product offerings.
Key players in the market
Some of the key players in Active Aging Nutrition include Nestle Health Science, Danone S.A., Abbott Laboratories, Herbalife Ltd., Amway Corporation, Glanbia plc, Bayer AG, Haleon plc, Blackmores Limited, Swisse Wellness Pty Ltd., Arla Foods Ingredients Group P/S, Kerry Group plc, Royal DSM-Firmenich, Ajinomoto Co., Inc., Orkla Health AS, Now Health Group, Inc. and Jamieson Wellness Inc..
In June 2026, Nestle Health Science launched a comprehensive active aging nutrition platform combining personalized supplement recommendations with digital health coaching, targeting adults over fifty with condition-specific nutritional protocols for cognitive and muscle health.
In May 2026, Abbott Laboratories expanded its Ensure clinical nutrition line with advanced protein and HMB formulations specifically designed to combat sarcopenia and maintain muscle mass in adults aged sixty-five and above.
In April 2026, Danone S.A. introduced a probiotic-rich functional yogurt targeting active aging consumers, featuring clinically validated strains for digestive health and immune support in older adults across European markets.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.